MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis

NASDAQ:MDLZ • US6092071058

60.015 USD
+0.16 (+0.26%)
Last: Feb 18, 2026, 01:54 PM
Fundamental Rating

4

MDLZ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 87 industry peers in the Food Products industry. There are concerns on the financial health of MDLZ while its profitability can be described as average. MDLZ has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year MDLZ was profitable.
  • MDLZ had a positive operating cash flow in the past year.
  • MDLZ had positive earnings in each of the past 5 years.
  • MDLZ had a positive operating cash flow in each of the past 5 years.
MDLZ Yearly Net Income VS EBIT VS OCF VS FCFMDLZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • MDLZ's Return On Assets of 3.43% is fine compared to the rest of the industry. MDLZ outperforms 65.52% of its industry peers.
  • With a decent Return On Equity value of 9.49%, MDLZ is doing good in the industry, outperforming 75.86% of the companies in the same industry.
  • MDLZ's Return On Invested Capital of 5.26% is fine compared to the rest of the industry. MDLZ outperforms 63.22% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MDLZ is significantly below the industry average of 28.07%.
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROIC 5.26%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
MDLZ Yearly ROA, ROE, ROICMDLZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • MDLZ's Profit Margin of 6.36% is amongst the best of the industry. MDLZ outperforms 81.61% of its industry peers.
  • MDLZ's Profit Margin has declined in the last couple of years.
  • MDLZ's Operating Margin of 9.48% is fine compared to the rest of the industry. MDLZ outperforms 74.71% of its industry peers.
  • In the last couple of years the Operating Margin of MDLZ has declined.
  • The Gross Margin of MDLZ (28.38%) is better than 66.67% of its industry peers.
  • MDLZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
OM growth 3Y-8%
OM growth 5Y-9.54%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
MDLZ Yearly Profit, Operating, Gross MarginsMDLZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. Health

2.1 Basic Checks

  • MDLZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • MDLZ has less shares outstanding than it did 1 year ago.
  • MDLZ has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for MDLZ is higher compared to a year ago.
MDLZ Yearly Shares OutstandingMDLZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
MDLZ Yearly Total Debt VS Total AssetsMDLZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • MDLZ has an Altman-Z score of 2.28. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
  • MDLZ has a Altman-Z score (2.28) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of MDLZ is 6.55, which is on the high side as it means it would take MDLZ, 6.55 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of MDLZ (6.55) is better than 68.97% of its industry peers.
  • A Debt/Equity ratio of 0.77 indicates that MDLZ is somewhat dependend on debt financing.
  • MDLZ has a Debt to Equity ratio of 0.77. This is in the lower half of the industry: MDLZ underperforms 60.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Altman-Z 2.28
ROIC/WACC0.71
WACC7.37%
MDLZ Yearly LT Debt VS Equity VS FCFMDLZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.59 indicates that MDLZ may have some problems paying its short term obligations.
  • With a Current ratio value of 0.59, MDLZ is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.39 indicates that MDLZ may have some problems paying its short term obligations.
  • MDLZ has a worse Quick ratio (0.39) than 80.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.39
MDLZ Yearly Current Assets VS Current LiabilitesMDLZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. Growth

3.1 Past

  • MDLZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.36%.
  • The Earnings Per Share has been growing slightly by 2.19% on average over the past years.
  • The Revenue has been growing slightly by 5.75% in the past year.
  • Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.71% on average per year.
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.76% on average over the next years. This is quite good.
  • Based on estimates for the next years, MDLZ will show a small growth in Revenue. The Revenue will grow by 3.25% on average per year.
EPS Next Y9.49%
EPS Next 2Y9.35%
EPS Next 3Y9.06%
EPS Next 5Y8.76%
Revenue Next Year3.69%
Revenue Next 2Y3.62%
Revenue Next 3Y3.94%
Revenue Next 5Y3.25%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDLZ Yearly Revenue VS EstimatesMDLZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
MDLZ Yearly EPS VS EstimatesMDLZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.55, MDLZ is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of MDLZ is on the same level as its industry peers.
  • MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.16.
  • With a Price/Forward Earnings ratio of 18.77, MDLZ is valued on the expensive side.
  • MDLZ's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 60.92% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of MDLZ to the average of the S&P500 Index (28.10), we can say MDLZ is valued slightly cheaper.
Industry RankSector Rank
PE 20.55
Fwd PE 18.77
MDLZ Price Earnings VS Forward Price EarningsMDLZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
  • MDLZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 63.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.78
EV/EBITDA 18.58
MDLZ Per share dataMDLZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)2.16
PEG (5Y)9.38
EPS Next 2Y9.35%
EPS Next 3Y9.06%

6

5. Dividend

5.1 Amount

  • MDLZ has a Yearly Dividend Yield of 3.23%.
  • MDLZ's Dividend Yield is a higher than the industry average which is at 2.27.
  • Compared to an average S&P500 Dividend Yield of 1.82, MDLZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.23%

5.2 History

  • The dividend of MDLZ is nicely growing with an annual growth rate of 10.23%!
  • MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
  • MDLZ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.23%
Div Incr Years11
Div Non Decr Years11
MDLZ Yearly Dividends per shareMDLZ Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 101.47% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
  • MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP101.47%
EPS Next 2Y9.35%
EPS Next 3Y9.06%
MDLZ Yearly Income VS Free CF VS DividendMDLZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
MDLZ Dividend Payout.MDLZ Dividend Payout, showing the Payout Ratio.MDLZ Dividend Payout.PayoutRetained Earnings

MONDELEZ INTERNATIONAL INC-A

NASDAQ:MDLZ (2/18/2026, 1:54:06 PM)

60.015

+0.16 (+0.26%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners89.35%
Inst Owner Change-1.49%
Ins Owners0.15%
Ins Owner Change5.05%
Market Cap76.93B
Revenue(TTM)38.54B
Net Income(TTM)2.45B
Analysts78.24
Price Target68.14 (13.54%)
Short Float %2.45%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 3.23%
Yearly Dividend1.91
Dividend Growth(5Y)10.23%
DP101.47%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.76%
Min EPS beat(2)0.24%
Max EPS beat(2)1.28%
EPS beat(4)4
Avg EPS beat(4)4.31%
Min EPS beat(4)0.24%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.06%
EPS beat(12)11
Avg EPS beat(12)5.53%
EPS beat(16)15
Avg EPS beat(16)5.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.15%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-0.15%
Revenue beat(8)0
Avg Revenue beat(8)-1.43%
Revenue beat(12)3
Avg Revenue beat(12)-0.47%
Revenue beat(16)7
Avg Revenue beat(16)0.45%
PT rev (1m)-2.02%
PT rev (3m)-6.37%
EPS NQ rev (1m)-20.77%
EPS NQ rev (3m)-23.75%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-2.18%
Revenue NQ rev (1m)-1.45%
Revenue NQ rev (3m)-1.64%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE 20.55
Fwd PE 18.77
P/S 2
P/FCF 23.78
P/OCF 17.04
P/B 2.98
P/tB N/A
EV/EBITDA 18.58
EPS(TTM)2.92
EY4.87%
EPS(NY)3.2
Fwd EY5.33%
FCF(TTM)2.52
FCFY4.21%
OCF(TTM)3.52
OCFY5.87%
SpS30.06
BVpS20.16
TBVpS-14.14
PEG (NY)2.16
PEG (5Y)9.38
Graham Number36.39
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROCE 7.37%
ROIC 5.26%
ROICexc 5.48%
ROICexgc 44.23%
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
FCFM 8.39%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
ROICexc(3y)8.16%
ROICexc(5y)7.43%
ROICexgc(3y)63.45%
ROICexgc(5y)50.76%
ROCE(3y)10.65%
ROCE(5y)9.63%
ROICexgc growth 3Y21.27%
ROICexgc growth 5Y4.15%
ROICexc growth 3Y1.33%
ROICexc growth 5Y-3.01%
OM growth 3Y-8%
OM growth 5Y-9.54%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Debt/EBITDA 3.97
Cap/Depr 94.18%
Cap/Sales 3.32%
Interest Coverage 6.41
Cash Conversion 90.05%
Profit Quality 131.99%
Current Ratio 0.59
Quick Ratio 0.39
Altman-Z 2.28
F-Score5
WACC7.37%
ROIC/WACC0.71
Cap/Depr(3y)97.41%
Cap/Depr(5y)92.16%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.29%
Profit Quality(3y)93.68%
Profit Quality(5y)93.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
EPS Next Y9.49%
EPS Next 2Y9.35%
EPS Next 3Y9.06%
EPS Next 5Y8.76%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%
Revenue Next Year3.69%
Revenue Next 2Y3.62%
Revenue Next 3Y3.94%
Revenue Next 5Y3.25%
EBIT growth 1Y-45.42%
EBIT growth 3Y-1.6%
EBIT growth 5Y-2.57%
EBIT Next Year37.45%
EBIT Next 3Y17.54%
EBIT Next 5Y13.29%
FCF growth 1Y-8.17%
FCF growth 3Y2.52%
FCF growth 5Y0.85%
OCF growth 1Y-8.07%
OCF growth 3Y4.92%
OCF growth 5Y2.63%

MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ

Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.


Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a valuation rating of 4 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Fairly Valued.


What is the profitability of MDLZ stock?

MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for MDLZ stock?

The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 20.55 and the Price/Book (PB) ratio is 2.98.


Can you provide the dividend sustainability for MDLZ stock?

The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 101.47%.